27,338 research outputs found
Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data.
Background and objectiveEarly detection methods for pancreatic cancer are lacking. We aimed to develop a prediction model for pancreatic cancer based on changes in health captured by healthcare claims data.MethodsWe conducted a case-control study on 29,646 Medicare-enrolled patients aged 68 years and above with pancreatic ductal adenocarcinoma (PDAC) reported to the Surveillance Epidemiology an End Results (SEER) tumor registries program in 2004-2011 and 88,938 age and sex-matched controls. We developed a prediction model using multivariable logistic regression on Medicare claims for 16 risk factors and pre-diagnostic symptoms of PDAC present within 15 months prior to PDAC diagnosis. Claims within 3 months of PDAC diagnosis were excluded in sensitivity analyses. We evaluated the discriminatory power of the model with the area under the receiver operating curve (AUC) and performed cross-validation by bootstrapping.ResultsThe prediction model on all cases and controls reached AUC of 0.68. Excluding the final 3 months of claims lowered the AUC to 0.58. Among new-onset diabetes patients, the prediction model reached AUC of 0.73, which decreased to 0.63 when claims from the final 3 months were excluded. Performance measures of the prediction models was confirmed by internal validation using the bootstrap method.ConclusionModels based on healthcare claims for clinical risk factors, symptoms and signs of pancreatic cancer are limited in classifying those who go on to diagnosis of pancreatic cancer and those who do not, especially when excluding claims that immediately precede the diagnosis of PDAC
Risk models and scores for type 2 diabetes: Systematic review
This article is published under a Creative Commons Attribution Non Commercial (CC BY-NC 3.0) licence that allows reuse subject only to the use being non-commercial and to the article being fully attributed (http://creativecommons.org/licenses/by-nc/3.0).Objective - To evaluate current risk models and scores for type 2 diabetes and inform selection and implementation of these in practice.
Design - Systematic review using standard (quantitative) and realist (mainly qualitative) methodology.
Inclusion - criteria Papers in any language describing the development or external validation, or both, of models and scores to predict the risk of an adult developing type 2 diabetes.
Data sources - Medline, PreMedline, Embase, and Cochrane databases were searched. Included studies were citation tracked in Google Scholar to identify follow-on studies of usability or impact.
Data extraction - Data were extracted on statistical properties of models, details of internal or external validation, and use of risk scores beyond the studies that developed them. Quantitative data were tabulated to compare model components and statistical properties. Qualitative data were analysed thematically to identify mechanisms by which use of the risk model or score might improve patient outcomes.
Results - 8864 titles were scanned, 115 full text papers considered, and 43 papers included in the final sample. These described the prospective development or validation, or both, of 145 risk prediction models and scores, 94 of which were studied in detail here. They had been tested on 6.88 million participants followed for up to 28 years. Heterogeneity of primary studies precluded meta-analysis. Some but not all risk models or scores had robust statistical properties (for example, good discrimination and calibration) and had been externally validated on a different population. Genetic markers added nothing to models over clinical and sociodemographic factors. Most authors described their score as “simple” or “easily implemented,” although few were specific about the intended users and under what circumstances. Ten mechanisms were identified by which measuring diabetes risk might improve outcomes. Follow-on studies that applied a risk score as part of an intervention aimed at reducing actual risk in people were sparse.
Conclusion - Much work has been done to develop diabetes risk models and scores, but most are rarely used because they require tests not routinely available or they were developed without a specific user or clear use in mind. Encouragingly, recent research has begun to tackle usability and the impact of diabetes risk scores. Two promising areas for further research are interventions that prompt lay people to check their own diabetes risk and use of risk scores on population datasets to identify high risk “hotspots” for targeted public health interventions.Tower Hamlets, Newham, and City and Hackney primary care trusts and National
Institute of Health Research
Dipole: Diagnosis Prediction in Healthcare via Attention-based Bidirectional Recurrent Neural Networks
Predicting the future health information of patients from the historical
Electronic Health Records (EHR) is a core research task in the development of
personalized healthcare. Patient EHR data consist of sequences of visits over
time, where each visit contains multiple medical codes, including diagnosis,
medication, and procedure codes. The most important challenges for this task
are to model the temporality and high dimensionality of sequential EHR data and
to interpret the prediction results. Existing work solves this problem by
employing recurrent neural networks (RNNs) to model EHR data and utilizing
simple attention mechanism to interpret the results. However, RNN-based
approaches suffer from the problem that the performance of RNNs drops when the
length of sequences is large, and the relationships between subsequent visits
are ignored by current RNN-based approaches. To address these issues, we
propose {\sf Dipole}, an end-to-end, simple and robust model for predicting
patients' future health information. Dipole employs bidirectional recurrent
neural networks to remember all the information of both the past visits and the
future visits, and it introduces three attention mechanisms to measure the
relationships of different visits for the prediction. With the attention
mechanisms, Dipole can interpret the prediction results effectively. Dipole
also allows us to interpret the learned medical code representations which are
confirmed positively by medical experts. Experimental results on two real world
EHR datasets show that the proposed Dipole can significantly improve the
prediction accuracy compared with the state-of-the-art diagnosis prediction
approaches and provide clinically meaningful interpretation
Delivering diabetes education through nurseled telecoaching : cost-effectiveness analysis
Background : People with diabetes have a high risk of developing micro-and macrovascular complications associated with diminished life expectancy and elevated treatment costs. Patient education programs can improve diabetes control in the short term, but their cost-effectiveness is uncertain. Our study aimed to analyze the lifelong cost-effectiveness of a nurse-led tele-coaching program compared to usual care in people with type 2 diabetes from the perspective of the Belgian healthcare system.
Methods : The UKPDS Outcomes Model was populated with patient-level data from an 18-month randomized clinical trial in the Belgian primary care sector involving 574 participants; trial data were extrapolated to 40 years; Quality Adjusted Life Years (QALYs), treatment costs and Incremental Cost-Effectiveness Ratio (ICER) were calculated for the entire cohort and the subgroup with poor glycemic control at baseline ("elevated HbA1c subgroup") and the associated uncertainty was explored.
Results : The cumulative mean QALY (95% CI) gain was 0.21 (0.13; 0.28) overall and 0.56 (0.43; 0.68) in elevated HbA1c subgroup; the respective incremental costs were (sic)1,147 (188; 2,107) and (sic)2,565 (654; 4,474) and the respective ICERs (sic)5,569 ((sic)677; (sic)15,679) and (sic)4,615 (1,207; 9,969) per QALY. In the scenario analysis, repeating the intervention for lifetime had the greatest impact on the cost-effectiveness and resulted in the mean ICERs of (sic) 13,034 in the entire cohort and (sic)7,858 in the elevated HbA1c subgroup.
Conclusion : Taking into account reimbursement thresholds applied in West-European countries, nurseled telecoaching of people with type 2 diabetes may be considered highly cost-effective within the Belgian healthcare system
Recommended from our members
A Comparison of Patient History- and EKG-based Cardiac Risk Scores.
Patient-specific risk scores are used to identify individuals at elevated risk for cardiovascular disease. Typically, risk scores are based on patient habits and medical history - age, sex, race, smoking behavior, and prior vital signs and diagnoses. We explore an alternative source of information, a patient's raw electrocardiogram recording, and develop a score of patient risk for various outcomes. We compare models that predict adverse cardiac outcomes following an emergency department visit, and show that a learned representation (e.g. deep neural network) of raw EKG waveforms can improve prediction over traditional risk factors. Further, we show that a simple model based on segmented heart beats performs as well or better than a complex convolutional network recently shown to reliably automate arrhythmia detection in EKGs. We analyze a large cohort of emergency department patients and show evidence that EKG-derived scores can be more robust to patient heterogeneity
Prediction of future hospital admissions - what is the tradeoff between specificity and accuracy?
Large amounts of electronic medical records collected by hospitals across the
developed world offer unprecedented possibilities for knowledge discovery using
computer based data mining and machine learning. Notwithstanding significant
research efforts, the use of this data in the prediction of disease development
has largely been disappointing. In this paper we examine in detail a recently
proposed method which has in preliminary experiments demonstrated highly
promising results on real-world data. We scrutinize the authors' claims that
the proposed model is scalable and investigate whether the tradeoff between
prediction specificity (i.e. the ability of the model to predict a wide number
of different ailments) and accuracy (i.e. the ability of the model to make the
correct prediction) is practically viable. Our experiments conducted on a data
corpus of nearly 3,000,000 admissions support the authors' expectations and
demonstrate that the high prediction accuracy is maintained well even when the
number of admission types explicitly included in the model is increased to
account for 98% of all admissions in the corpus. Thus several promising
directions for future work are highlighted.Comment: In Proc. International Conference on Bioinformatics and Computational
Biology, April 201
- …